CorMedix (CRMD) Current Assets (2010 - 2025)

CorMedix (CRMD) has 15 years of Current Assets data on file, last reported at $367.1 million in Q4 2025.

• For the quarter ending Q4 2025, Current Assets rose 220.36% year-over-year to $367.1 million; the trailing twelve-month figure through Dec 2025 stood at $367.1 million (up 220.36% YoY), and the FY2025 full-year result was $367.1 million, up 220.36% from the prior year.
• Current Assets climbed to $367.1 million in Q4 2025, from $259.5 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $367.1 million in Q4 2025 to a low of $53.2 million in Q2 2024.
• A 5-year average of $107.7 million and a median of $73.1 million in 2021 frame the typical range for Current Assets.
• Across the five-year window, Current Assets slipped 24.75% in 2022 and soared 366.32% in 2025, its largest moves.
• Tracing CRMD's Current Assets over 5 years: stood at $66.5 million in 2021, then decreased by 10.41% to $59.6 million in 2022, then soared by 33.42% to $79.5 million in 2023, then surged by 44.21% to $114.6 million in 2024, then jumped by 220.36% to $367.1 million in 2025.
• Business Quant data shows CRMD's Current Assets at $367.1 million in Q4 2025, $259.5 million in Q3 2025, and $248.1 million in Q2 2025.